LEONI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 9.260
EU - Europa 6.434
AS - Asia 2.804
SA - Sud America 587
AF - Africa 236
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 8
Totale 19.354
Nazione #
US - Stati Uniti d'America 9.206
UA - Ucraina 1.391
SG - Singapore 847
SE - Svezia 839
IT - Italia 759
IE - Irlanda 706
RU - Federazione Russa 697
DE - Germania 688
TR - Turchia 659
BR - Brasile 554
DK - Danimarca 541
HK - Hong Kong 442
CN - Cina 424
FI - Finlandia 334
KR - Corea 290
GB - Regno Unito 197
FR - Francia 167
CI - Costa d'Avorio 113
MA - Marocco 106
IN - India 52
CA - Canada 30
BE - Belgio 27
EU - Europa 25
MX - Messico 15
ES - Italia 14
JP - Giappone 14
NL - Olanda 14
AT - Austria 13
PL - Polonia 12
UZ - Uzbekistan 12
BD - Bangladesh 10
CZ - Repubblica Ceca 10
IQ - Iraq 10
RO - Romania 9
AR - Argentina 8
EC - Ecuador 8
PK - Pakistan 8
ZA - Sudafrica 8
AU - Australia 6
CO - Colombia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
GR - Grecia 4
JO - Giordania 4
NP - Nepal 4
OM - Oman 4
AZ - Azerbaigian 3
BZ - Belize 3
CH - Svizzera 3
HR - Croazia 3
KE - Kenya 3
BG - Bulgaria 2
IR - Iran 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
NG - Nigeria 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 19.354
Città #
Jacksonville 1.424
Chandler 1.049
Fairfield 779
Boardman 704
Dublin 704
Ashburn 478
Wilmington 473
Singapore 471
Hong Kong 440
Woodbridge 351
New York 294
San Mateo 291
Houston 290
Lawrence 286
Princeton 286
Seattle 284
Des Moines 233
Cambridge 212
Ann Arbor 189
Centro 166
Moscow 154
San Diego 116
Abidjan 113
Beijing 109
Redmond 93
The Dalles 80
Porto 79
Turin 53
Los Angeles 49
Shanghai 42
Munich 41
Milan 39
São Paulo 35
Guangzhou 32
Helsinki 30
London 29
Pune 29
Norwalk 27
Pianella 27
Dallas 26
Brussels 25
Marche 23
Izmir 19
Turku 19
Auburn Hills 16
Civitanova Marche 15
Wuhan 15
Ancona 14
Washington 14
Rio de Janeiro 13
Rome 13
Brooklyn 12
Nuremberg 12
Tashkent 12
Belo Horizonte 11
Tokyo 11
Curitiba 10
Jinhua 10
Olomouc 10
Prescot 10
Stockholm 10
Venice 10
Wuxi 10
Falls Church 9
San Francisco 9
Warsaw 9
Brasília 8
Istanbul 8
Mexico City 8
New Bedfont 8
Boston 7
Campinas 7
Fayetteville 7
Porto Alegre 7
Santa Clara 7
Vienna 7
Catania 6
Chennai 6
Goiânia 6
Hyderabad 6
Jesi 6
Jiaxing 6
Kilburn 6
Ottawa 6
Phoenix 6
Ribeirão Preto 6
Shenzhen 6
Toronto 6
Baghdad 5
Campo Grande 5
Chicago 5
Chiswick 5
Frankfurt am Main 5
Hangzhou 5
Joinville 5
Leeds 5
Naples 5
Nova Iguaçu 5
Quanzhou 5
Sydney 5
Totale 11.154
Nome #
Human white adipocytes convert into “rainbow” adipocytes in vitro 206
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 148
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 146
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 133
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 129
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 119
Glial-like differentiation potential of human mature adipocytes 119
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 116
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 116
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 115
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 113
Primary B-cell lymphoblastic lymphoma of the testis 113
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 109
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 109
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 108
Meningioma-like cerebral relapse of Hodgkin's disease. 108
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 107
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 106
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 105
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: The role of the WHO histological diagnosis 104
Plasticity of human dedifferentiated adipocytes toward endothelial cells 102
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 102
Biosafety evidence for human dedifferentiated adipocytes 101
Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides. 101
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 100
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 100
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 100
Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. 99
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 99
Ematuria ed emospermia ricorrenti: uniche manifestazioni di malattia di von Willebrand di tipo I. First report 99
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 98
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 97
Severe diarrhoea During Campath-1H Treatment For Refractory Cutaneous T Cell Lymphoma 97
Molecular and functional characterization of human bone marrow adipocytes 96
Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: a possible overlapping between micovillous lymphomas and sinusal CD30-positive large B-cell lymphomas. 94
Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas 94
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 94
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase 3 study 92
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 92
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 92
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 92
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 92
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 91
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 91
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 90
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 89
Immunostaining for nucleophosmin in bone marrow trephine biopsy specimens in acute myeloid leukemias 89
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 89
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 88
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 88
Bone marrow adipocytes support haematopoietic stem cell survival 88
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 87
Prognostic clinical, laboratoristic and molecular factors in mycosis fungoides 87
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 87
The value of PCR in the diagnosis and monitoring of early stage of mycosis fungoids treated with Interferon plus PUVA 87
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 87
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 86
[Hodgkin's lymphoma and secondary leukemias]. 86
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 85
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial 85
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 85
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 85
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 85
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 85
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 84
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 84
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 84
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 84
High remission rate in T-Cell prolymphocytic leukemia with Campath-1H 83
A circulating T cell clone in early Mycosis Fungoides is not a negative prognostic factor when the disease is treated by a combination of PUVA plus interferon alpha 83
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 83
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 83
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 83
A case of monoclonal gammopathy of undetermined significance (MGUS): type IgD-lambda. 83
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies. 83
Risk assessment of patients with Hematologic malignancies who develop fever accompanied by pulmonary infiltrates. A historic cohort study. 82
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma 82
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 82
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 82
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 82
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 81
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 81
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 81
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II stud 80
Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. 80
Clonal TCR gamma e TCR delta rearrangement in peripheral blood in MF/SS patients 79
Prospective multicentric Clinical trial on the use of Interferon-a plus PUVA in patients with early stage Mycosis Fungoides. 79
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 79
Risk of non-Hodgkin lymphoma in celiac disease 78
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. 78
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 78
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 78
Central nervous system involvement is a negative prognostic factor in primary cutaneous B-cell lymphoma. 78
Early stage Mycosis Fungoides treated with IFNalpha2b and PUVA: molecular analysis of T cell monoclonality by PCR in skin biopsies during and after therapy. 77
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 77
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry. 77
TIME TO NEXT TREATMENT ANALYSIS FOR EARLY AND ADVANCED STAGES OF MYCOSIS FUNGOIDES/SEZARY SYNDROME TREATED WITH BEXAROTENE AND PUVA IN COMBINATION 77
CD8+ lymphocytes and CD1a+ dendritic cells in mycosis fungoides: correlation with epidermotropism, subepidermal lymphoid infiltrate, response to therapy and disease recurrence 76
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 76
Response to fludarabina in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy 75
Totale 9.374
Categoria #
all - tutte 106.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020345 0 0 0 0 0 0 0 0 0 0 0 345
2020/20213.524 145 386 545 38 471 193 358 162 426 266 388 146
2021/20222.187 99 620 23 176 16 79 99 171 115 178 158 453
2022/20233.296 343 373 278 258 254 492 1 172 864 19 178 64
2023/20241.955 350 49 102 341 334 369 27 46 5 38 20 274
2024/20253.857 429 424 172 48 169 78 486 113 868 285 353 432
Totale 19.715